PE-22-28

PE-22-28 is a peptide studied in research settings for its potential role in neurogenesis, the creation of new nerve cells, and synaptogenesis, the formation of new neural connections, in the hippocampus.

Research has also examined its interaction with TREK-1, a channel protein that has been associated with mood regulation.

PE-22-28 is an investigational compound and research remains early. It is not a substitute for prescribed treatment, individual responses vary, and its use is determined by a licensed physician following a medical review.

Research into PE-22-28 has explored its potential role in neurogenesis, mood regulation and cognitive function. Findings to date are early and largely preclinical, individual responses vary, and no specific outcome can be guaranteed. Your physician can discuss what is currently known during your consultation.

The administration method for PE-22-28 varies and is determined by your prescribing physician. It is administered under medical supervision.

Individuals with a history of hypersensitivity to peptides or those currently pregnant or breastfeeding should avoid using PE-22-28. Always consult with a healthcare provider before starting any new medication.

PE-22-28 is being studied in research settings in relation to mood regulation and cognitive wellness. Research remains early and it is not an approved treatment for any condition. Your physician can discuss what is currently known during your consultation.